Drugs / Fluorine F 18 DCFPyL
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04910425 | Jun 2023 → Jun 2026 | prostate carcinoma | Northwestern University | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluorine F 18 DCFPyL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04910425 ↗ |
| Modality | Diagnostic / imaging agent | “18F-DCFPyl is a radioactive injectable imaging agent” NCT04910425 ↗ |
| Route | Intravenous | “Given IV” NCT04910425 ↗ |